Last quarter (Q3 2024), United Therapeutics's total revenue was $748.90M, an increase of 22.89% from the same quarter last year. In Q3, United Therapeutics's net income was $309.10M. See United Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 2.76B	$ 2.33B	$ 1.94B	$ 1.69B	$ 1.48B	$ 1.45B
Cost of Revenue	$ 304.80M	$ 257.50M	$ 151.60M	$ 122.50M	$ -108.10M	$ -117.60M
Gross Profit	$ 2.45B	$ 2.07B	$ 1.78B	$ 1.56B	$ 1.38B	$ 995.00M
Operating Expense	$ 1.17B	$ 885.10M	$ 805.00M	$ 540.10M	$ 357.70M	$ 1.18B
Operating Income	$ 1.28B	$ 1.18B	$ 979.70M	$ 555.90M	$ 593.60M	$ -187.60M
Net Non Operating Interest Income Expense	$ 172.40M	$ 103.40M	$ 12.80M	$ -1.90M	$ 5.10M	$ ―
Other Income Expense	$ -35.80M	$ -14.00M	$ -41.90M	$ -39.90M	$ -40.20M	$ -22.60M
Pretax Income	$ 1.44B	$ 1.27B	$ 950.60M	$ 593.90M	$ 638.90M	$ -165.00M
Tax Provision	$ 327.00M	$ 289.50M	$ 223.30M	$ 118.10M	$ 124.10M	$ -60.50M
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ 1.12B	$ 984.80M	$ 727.30M	$ 475.80M	$ 514.80M	$ -104.50M
Basic EPS	$ 24.31	$ 21.04	$ 15.98	$ 10.60	$ 11.65	$ -2.39
Diluted EPS	$ 22.74	$ 19.81	$ 15.00	$ 10.06	$ 11.54	$ -2.39
Basic Average Shares	$ 183.10M	$ 46.80M	$ 45.50M	$ 44.90M	$ 44.20M	$ 43.80M
Diluted Average Shares	$ 195.60M	$ 49.70M	$ 48.50M	$ 47.30M	$ 44.60M	$ 43.80M
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ 1.48B	$ 1.14B	$ 956.60M	$ 662.60M	$ 249.60M	$ 1.06B
Net Income From Continuing And Discontinued Operation	$ 1.11B	$ 984.80M	$ 727.30M	$ 475.80M	$ 514.80M	$ -104.50M
Normalized Income	$ 970.03M	$ 1.01B	$ ―	$ ―	$ 508.43M	$ -242.70M
Interest Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
EBIT	$ 1.47B	$ 1.33B	$ 983.00M	$ 612.50M	$ 662.40M	$ -120.80M
EBITDA	$ 1.53B	$ 1.39B	$ 1.03B	$ 662.40M	$ 712.30M	$ -74.90M

Currency in USD

United Therapeutics Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing